131 related articles for article (PubMed ID: 25522898)
1. Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant.
Cantarini L; Lopalco G; Vitale A; Caso F; Lapadula G; Iannone F; Galeazzi M; Rigante D
Int J Rheum Dis; 2015 May; 18(4):473-5. PubMed ID: 25522898
[No Abstract] [Full Text] [Related]
2. Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
La Torre F; Muratore M; Vitale A; Moramarco F; Quarta L; Cantarini L
Rheumatol Int; 2015 Nov; 35(11):1943-7. PubMed ID: 26048626
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor receptor-associated periodic syndrome in a pediatric patient: A genetic diagnosis.
Yakhmi N; Knutsen AP
Ann Allergy Asthma Immunol; 2020 Oct; 125(4):369-371. PubMed ID: 32376455
[No Abstract] [Full Text] [Related]
4. Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A.
Nedjai B; Quillinan N; Coughlan RJ; Church L; McDermott MF; Hitman GA; Turner MD
Adv Exp Med Biol; 2011; 691():409-19. PubMed ID: 21153346
[No Abstract] [Full Text] [Related]
5. Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome.
Terré A; Vautier M; Kahn JE; Georgin-Lavialle S; Boursier G
Eur J Intern Med; 2024 May; 123():156-158. PubMed ID: 38307733
[No Abstract] [Full Text] [Related]
6. TNFRSF1A Gene Causing Tumor Necrosis Factor Receptor-associated Periodic Syndrome in 2 Siblings Displaying Variable Disease Severity and Discordant Heterozygosity for an MEFV E148Q Variant.
Abdwani R; Abdalla E; Al Abrawi S; Al-Thihli K
J Rheumatol; 2015 Aug; 42(8):1534-5. PubMed ID: 26233954
[No Abstract] [Full Text] [Related]
7. Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome.
Pucino V; Lucherini OM; Perna F; Obici L; Merlini G; Cattalini M; La Torre F; Maggio MC; Lepore MT; Magnotti F; Galgani M; Galeazzi M; Marone G; De Rosa V; Talarico R; Cantarini L; Matarese G
J Leukoc Biol; 2016 May; 99(5):761-9. PubMed ID: 26598380
[TBL] [Abstract][Full Text] [Related]
8. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up.
Cantarini L; Rigante D; Merlini G; Vitale A; Caso F; Lucherini OM; Sfriso P; Frediani B; Punzi L; Galeazzi M; Cimaz R; Obici L
Semin Arthritis Rheum; 2014 Jun; 43(6):818-23. PubMed ID: 24393624
[TBL] [Abstract][Full Text] [Related]
9. A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without TNFRSF1A Mutations Successfully Treated with Tocilizumab.
Hosoya T; Mizoguchi F; Hasegawa H; Miura K; Koike R; Kubota T; Miyasaka N; Kohsaka H
Intern Med; 2015; 54(16):2069-72. PubMed ID: 26278305
[TBL] [Abstract][Full Text] [Related]
10. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
De Benedetti F; Gattorno M; Anton J; Ben-Chetrit E; Frenkel J; Hoffman HM; Koné-Paut I; Lachmann HJ; Ozen S; Simon A; Zeft A; Calvo Penades I; Moutschen M; Quartier P; Kasapcopur O; Shcherbina A; Hofer M; Hashkes PJ; Van der Hilst J; Hara R; Bujan-Rivas S; Constantin T; Gul A; Livneh A; Brogan P; Cattalini M; Obici L; Lheritier K; Speziale A; Junge G
N Engl J Med; 2018 May; 378(20):1908-1919. PubMed ID: 29768139
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year-old man: caution not to discount TRAPS as a diagnosis in older patients.
Sinožić D; Toplak N; Milotić I
J Clin Rheumatol; 2011 Sep; 17(6):325-8. PubMed ID: 21869706
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment.
Cantarini L; Lucherini OM; Galeazzi M; Fanti F; Simonini G; Baldari CT; Laghi Pasini F; De Martino M; Cimaz R
Clin Exp Rheumatol; 2009; 27(5):890-1. PubMed ID: 19917181
[No Abstract] [Full Text] [Related]
13. On-demand treatment with anakinra: a treatment option for selected TRAPS patients.
Grimwood C; Despert V; Jeru I; Hentgen V
Rheumatology (Oxford); 2015 Sep; 54(9):1749-51. PubMed ID: 26078218
[No Abstract] [Full Text] [Related]
14. Inflammatory response to heparinoid and heparin in a patient with tumor necrosis factor receptor-associated periodic syndrome: the second case with a T61I mutation in the TNFRSF1A gene.
Ohmori S; Hino R; Nakamura M
J Dermatol; 2014 Dec; 41(12):1112-3. PubMed ID: 25387410
[No Abstract] [Full Text] [Related]
15. Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral center.
Nezos A; Argyropoulou OD; Klinaki E; Marketos N; Karagianni P; Eliopoulos E; Vlachoyiannopoulos P; Maritsi DN; Tzioufas AG
Rheumatology (Oxford); 2020 Jun; 59(6):1241-1246. PubMed ID: 31562507
[TBL] [Abstract][Full Text] [Related]
16. A novel TNFRSF1A gene mutation in a patient with tumor necrosis factor receptor-associated periodic syndrome.
Khabazi A; Maralani M; Andalib S; Sakhinia E
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):175-177. PubMed ID: 27793577
[TBL] [Abstract][Full Text] [Related]
17. [Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art].
Georgin-Lavialle S; Kone-Paut I; Delaleu J; Sarrabay G; Grateau G; Touitou I; Hentgen V
Rev Med Interne; 2018 Apr; 39(4):256-264. PubMed ID: 29525418
[TBL] [Abstract][Full Text] [Related]
18. Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome.
Quillinan N; Mannion G; Mohammad A; Coughlan R; Dickie LJ; McDermott MF; McGonagle D
Ann Rheum Dis; 2011 Sep; 70(9):1692-3. PubMed ID: 21378401
[No Abstract] [Full Text] [Related]
19. Canakinumab for the treatment of TNF-receptor associated periodic syndrome.
La Torre F; Caparello MC; Cimaz R
Expert Rev Clin Immunol; 2017 Jun; 13(6):513-523. PubMed ID: 28454496
[TBL] [Abstract][Full Text] [Related]
20. Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report.
Radhakrishna SM; Grimm A; Broderick L
BMC Pediatr; 2017 Apr; 17(1):108. PubMed ID: 28427379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
